Sitharthan Sekar
Papers
1
Total Citations
10
H-Index
1
About
Dr. Sitharthan Sekar is a urologic oncologist whose research focuses on improving risk stratification and treatment decision-making in prostate cancer. His most cited work challenges conventional clinical guidelines by demonstrating that over half of contemporary clinical Gleason 8 prostate cancers identified on biopsy are downgraded at radical prostatectomy. This pivotal finding, published in 2017 and garnering 10 citations, underscores the significant discrepancy between biopsy-based risk classification and final pathology, directly impacting how high-risk prostate cancer is managed. Dr. Sekar’s contributions highlight the limitations of current biopsy grading systems and advocate for more nuanced approaches to avoid overtreatment. His research bridges the gap between clinical practice and pathological reality, offering critical insights for urologists and oncologists. By quantifying this diagnostic discordance, Dr. Sekar has helped refine risk assessment, ultimately guiding more personalized therapeutic strategies for patients. His work remains a key reference in discussions on prostate cancer grading accuracy and treatment selection.
Research Focus
Key Achievements
Top Papers
- 1